Pneumococcal Vaccination in Europe: Schedule Adherence

被引：16

作者：

Gervaix, Alain ^{[1
]}

Ansaldi, Filippo ^{[2
,3
]}

Brito-Avo, Antonio ^{[4
]}

Azzari, Chiara ^{[5
,6
]}

Knuf, Markus ^{[7
,8
]}

Martinon-Torres, Federico ^{[9
,10
]}

Tuerlinckx, David ^{[11
]}

Htar, Myint Tin Tin ^{[12
]}

Syrogiannopoulos, George A. ^{[13
]}

机构：

[1] Univ Childrens Hosp, Paediat Emergency Med Serv, Geneva, Switzerland

[2] Univ Genoa, Genoa, Italy

[3] IRCCS AOU San Martino IST, Genoa, Italy

[4] Pediat Clin, Lisbon, Portugal

[5] Univ Florence, Florence, Italy

[6] Anna Meyer Childrens Hosp, Florence, Italy

[7] Dr Horst Schmidt Kliniken, Klinikum Landeshauptstadt Wiesbaden HSK, Wiesbaden, Germany

[8] Univ Med Mainz, Mainz, Germany

[9] Hosp Clin Univ Santiago de Compostela, Santiago, Spain

[10] Inst Invest Sanitaria Santiago, Genet Vaccines Infect & Pediat Res Grp GENVIP, Santiago, Spain

[11] Catholic Univ Louvain, Ctr Hosp Univ Mont Godinne, Dept Pediat, Yvoir, Belgium

[12] Pfizer Inc, Paris, France

[13] Univ Thessaly, Dept Pediat, Sch Hlth Sci, Fac Med,Gen Univ Hosp Larissa,Biopolis, Larisa, Greece

来源：

CLINICAL THERAPEUTICS | 2014年 / 36卷 / 05期

关键词：

pneumococcal conjugate vaccine; Streptococcus pneumoniae; vaccination schedule adherence; vaccine uptake; CONJUGATE VACCINE; PNEUMONIA; CHILDREN; TRENDS; EFFICACY; COVERAGE; ENGLAND; DISEASE; IMPACT;

D O I：

10.1016/j.clinthera.2014.03.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Nonadherence to recommended pneumococcal conjugate vaccine (PCV) schedules may have implications for protection against pneumococcal disease. In this commentary, we have assessed adherence to the recommended dosing schedules (the completion of the primary PCV and booster series) in different European countries. We found that adherence with the PCV schedule was lower than that for diphtheria-tetanus-acellular pertussis (DTaP) and that higher adherence was observed in countries where PCV vaccination is recommended and funded. Adherence with the booster dose is often lower than that with the primary series completion, and it is often given after the recommended age. These data highlight the need to encourage timely vaccination of children with PCV, in line with local immunization schedules. There is no single solution to improve adherence; actions need to be tailored to the context of individual countries through initiatives at the national, regional, and local levels and should target different stakeholders. (C) 2014 Elsevier HS Journals, Inc. All rights reserved.

引用

页码：802 / 812

页数：11

共 50 条

[21] What do the next 100 years hold for pneumococcal vaccination?
Rijkers, Ger T.
van Mens, Suzan P.
van Velzen-Blad, Heleen
EXPERT REVIEW OF VACCINES, 2010, 9 (11) : 1241 - 1244
[22] Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study
Luca, Dara Lee
Kwong, Jeffrey C.
Chu, Anna
Sander, Beate
O'Reilly, Ryan
McGeer, Allison J.
Bloom, David E.
CLINICAL INFECTIOUS DISEASES, 2018, 66 (04) : 541 - 547
[23] Value of pneumococcal vaccination in controlling the development of antimicrobial resistance (AMR): Case study using DREAMR in Ethiopia
Ozawa, Sachiko
Chen, Hui-Han
Rao, Gauri G.
Eguale, Tadesse
Stringer, Andrew
VACCINE, 2021, 39 (45) : 6700 - 6711
[24] Pneumococcal vaccination reduced the risk of acute otitis media: Cohort study
Hasegawa, Junko
Mori, Mitsuru
Showa, Satoko
Matsushima, Aiko
Ohnishi, Hirofumi
Tsugawa, Takeshi
Yoto, Yuko
Tsutsumi, Hiroyuki
PEDIATRICS INTERNATIONAL, 2015, 57 (04) : 582 - 585
[25] Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination-statistical analysis plan
Mackenzie, Grant A. A.
Palmu, Arto A. A.
Jokinen, Jukka
Osei, Isaac
Flasche, Stefan
Greenwood, Brian
Mulholland, Kim
Nguyen, Cattram
TRIALS, 2022, 23 (01)
[26] Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland
Polkowska, Aleksandra
Rinta-Kokko, Hanna
Toropainen, Maija
Palmu, Arto A.
Nuorti, J. Pekka
VACCINE, 2021, 39 (23) : 3216 - 3224
[27] Optimal age targeting for pneumococcal vaccination in older adults; a modelling study
Thindwa, Deus
Clifford, Samuel
Kleynhans, Jackie
von Gottberg, Anne
Walaza, Sibongile
Meiring, Susan
Swarthout, Todd D.
Miller, Elizabeth
McIntyre, Peter
Andrews, Nick
Amin-Chowdhury, Zahin
Fry, Norman
Jambo, Kondwani C.
French, Neil
Almeida, Samanta Cristine Grassi
Ladhani, Shamez N.
Heyderman, Robert S.
Cohen, Cheryl
de Cunto Brandileone, Maria Cristina
Flasche, Stefan
NATURE COMMUNICATIONS, 2023, 14 (01)
[28] Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: Population-based cross-sectional surveys
MacKenzie, Grant A.
Hossain, Ilias
Salaudeen, Rasheed
Badji, Henry
Manjang, Ahmed
Usuf, Effua
Bottomley, Christian
Greenwood, Brian
Hill, Philip C.
VACCINE, 2024, 42 (10) : 2680 - 2686
[29] Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea
Jung, Yeon Haw
Choe, Yong June
Lee, Chae Young
Jung, Sang Oun
Lee, Dong Han
Yoo, Jae Il
SCIENTIFIC REPORTS, 2022, 12 (01)
[30] The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage
Ciruela, Pilar
Izquierdo, Conchita
Broner, Sonia
Munoz-Almagro, Carmen
Hernandez, Sergi
Ardanuy, Carmen
Pallares, Roman
Dominguez, Angela
Jane, Mireia
Ciruela, P.
Izquierdo, C.
Broner, S.
Hernandez, S.
Jane, M.
Munoz-Almagro, C.
Esteva, C.
de Sevilla, M. F.
Henares, D.
Pallares, R.
Ardanuy, C.
Grau, I.
Marco, F.
Llaberia, J.
Gonzalez-Cuevas, A.
Diaz, A.
Martin, M. T.
Sierra, M.
Curriu, M.
Galles, C.
Hernandez, P.
Gassiot, P.
Martinez-Zurita, M.
Marti, C.
Morta, M.
Sauca, G.
Gassos, A.
Sanfeliu, E.
Ballester, F.
Pujol, I.
Olsina, M.
Raga, X.
Gomez-Bertomeu, F.
Perez-Moreno, M. O.
Vilamala, A.
Navarro, M.
Ribelles, M.
Padilla, E.
Prim, N.
Fontanals, D.
Benitez, M. A.
VACCINE, 2018, 36 (50) : 7744 - 7752

← 1 2 3 4 5 →